[1]
J. Miller, “Proteomic Profiling of IGFBP2: Modulation and Biomarker Potential in Atherosclerotic Cardiovascular Disease Prevention: Modulation and Biomarker Potential in Atherosclerotic Cardiovascular Disease Prevention ”, HSI, vol. 14, pp. 57–62, Sep. 2025.